According to a recent Kaiser Family Foundation poll, roughly 6% of U.S. adults are currently taking GLP-1 for weight loss, ...

If you're following the GLP-1 (Ozempic and other prescription weight-loss medications) scene, you may have read that the FDA ...

Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.

A U.S. federal judge has sided with a U.S. regulator's decision last year to take Eli Lilly’s blockbuster weight loss and ...

Fashion and beauty’s new appetite for collaborating with food brands collides with a worrying return to ’90s-era thinness and ...

Metamorphx is emerging as a leading natural GLP-1 alternative for weight loss in 2025. With prescription options like ...

Sometimes, it makes sense to skip insurance and instead take advantage of a health savings account or flexible savings ...

With Wegovy in its portfolio, Novo Nordisk is a very good bet to continue being a winner. As it's currently considered something of an underdog, with its stock priced accordingly, it's also trading at ...

After going after the companies making compounded versions of their drugs, GLP-1 makers are now going into business with the online telehealth sites that were previously selling the copycats.

Mukhopadhyay took Mounjaro, an antidiabetic medication also used for weight loss, and saw dramatic results—losing 15 percent ...

With GLP-1 shortage officially over, patients who relied on compounded copies have only bad options to choose from ...

All of them have recently been spotted looking leaner and, fingers every single time, point towards the new obsession in town - Ozempic and Mounjaro. Photos of Vidya Balan and Karan Johar before ...